Trump says prices for Ozempic, other weight-loss drugs to drop in U.S. - National | Globalnews.caNovember 6, 2025#Ozempic#orforglipron#weight-loss#Medicaid#Medicare#glp1-agonist#backfilled·globalnews.ca·Nov 7, 2025Trump says prices for Ozempic, other weight-loss drugs to drop in U.S. - National | Globalnews.ca
On biostatistics and clinical trials: FDA Commissioner's national priority voucher (CNPV) program versus Priority Review Voucher (PRV)November 6, 2025#Ketamine#orforglipron#Wegovy#glp1-agonist#backfilled·onbiostatistics.blogspot.com·Nov 7, 2025On biostatistics and clinical trials: FDA Commissioner's national priority voucher (CNPV) program versus Priority Review Voucher (PRV)
Innovent, Lilly's mazdutide outdoes Novo's semaglutide in phase 3 trial | TechTargetOctober 27, 2025#semaglutide#Eli-Lilly#mazdutide#glp1-agonist#backfilled·techtarget.com·Oct 29, 2025Innovent, Lilly's mazdutide outdoes Novo's semaglutide in phase 3 trial | TechTarget
Opinion: Stop illegally manufacturing Ozempic-like drugs - Portland Business JournalOctober 28, 2025#OSPA#Oregon#compounding#glp1-agonist#op-ed#backfilled·bizjournals.com·Oct 28, 2025Opinion: Stop illegally manufacturing Ozempic-like drugs - Portland Business Journal
Mum, 53, dies after being injected with £20 'skinny jab' | Wales OnlineOctober 27, 2025#United-Kingdom#black-market#glp1-agonist#semaglutide#death#backfilled·walesonline.co.uk·Oct 27, 2025Mum, 53, dies after being injected with £20 'skinny jab' | Wales Online
Eli Lilly v. Kennedy (S.D. Ind. Oct. 3, 2025): When is a peptide a “protein”—and who gets to decide?October 25, 2025,#retatrutide#glp1-agonist#backfilled·trialsitenews.com·Oct 27, 2025Eli Lilly v. Kennedy (S.D. Ind. Oct. 3, 2025): When is a peptide a “protein”—and who gets to decide?
I’m stuck in the gray market for GLP-1s | STATOctober 24, 2025#op-ed#gray-market#glp1-agonist#backfilled·statnews.com·Oct 24, 2025I’m stuck in the gray market for GLP-1s | STAT
MHRA smashes major illicit weight loss medicine production facility in record seizure - GOV.UKOctober 24, 2025#United-Kingdom#MHRA#glp1-agonist#counterfeit-injections#tirzepatide#retatrutide#manufacturing#backfilled·gov.uk·Oct 24, 2025MHRA smashes major illicit weight loss medicine production facility in record seizure - GOV.UK
Ozempic maker wins High Court ban on fake fat jab websitesOctober 18, 2025#United-Kingdom#Novo-Nordisk#glp1-agonist#semaglutide#Ozempic#backfilled·yahoo.com·Oct 20, 2025Ozempic maker wins High Court ban on fake fat jab websites
Health agency seizes 'unsafe' fake weight-loss injections wrongly containing insulinOctober 10, 2025#Ireland#Mounjaro#counterfeit-injections#glp1-agonist#Insulin#backfilled·thejournal.ie·Oct 16, 2025Health agency seizes 'unsafe' fake weight-loss injections wrongly containing insulin
What Chinese companies don't want you to know about fake weight loss drugsSeptember 17, 2025#Alabama#op-ed#counterfeit-injections#glp1-agonist#backfilled·alpolitics.com·Oct 15, 2025What Chinese companies don't want you to know about fake weight loss drugs
Inside the hunt for counterfeit 'faux-zempic' - Good Morning AmericaOctober 9, 2025#counterfeit-drugs#Ozempic#glp1-agonist#backfilled·goodmorningamerica.com·Oct 13, 2025Inside the hunt for counterfeit 'faux-zempic' - Good Morning America
Urgent Warning Over New £30 'Ozempic-like’ Weight Loss PILLS That Are ‘Better Than Mounjaro’ - As ‘Fakes’ Flood TikTok | The SunOctober 8, 2025#retatrutide#orforglipron#research-drugs#MHRA#glp1-agonist#United-Kingdom#backfilled·thesun.co.uk·Oct 8, 2025Urgent Warning Over New £30 'Ozempic-like’ Weight Loss PILLS That Are ‘Better Than Mounjaro’ - As ‘Fakes’ Flood TikTok | The Sun
Ozempic maker urges Ottawa to shut down online drug sales to Americans - The LogicOctober 1, 2025#Ozempic#Novo-Nordisk#semaglutide#Canada#glp1-agonist#backfilled·thelogic.co·Oct 6, 2025Ozempic maker urges Ottawa to shut down online drug sales to Americans - The Logic
I bought 'Godzilla' jab on Facebook Black Market - it's Cheaper to Buy Than Mounjaro... I Don't Care About Deadly Risks | The SunOctober 2, 2025#retatrutide#United-Kingdom#glp1-agonist#backfilled·thesun.co.uk·Oct 2, 2025I bought 'Godzilla' jab on Facebook Black Market - it's Cheaper to Buy Than Mounjaro... I Don't Care About Deadly Risks | The Sun
'Illegal Triple G' fat jabs dubbed the 'Godzilla' of weight loss drugs flooding UK are 'FAKE', experts warn | The SunSeptember 30, 2025#retatrutide#glp1-agonist#counterfeit-drugs#United-Kingdom#backfilled·thesun.co.uk·Sep 30, 2025'Illegal Triple G' fat jabs dubbed the 'Godzilla' of weight loss drugs flooding UK are 'FAKE', experts warn | The Sun
North Texas sheriff warns of counterfeit weight loss drugs possibly linked to violent illness – NBC 5 Dallas-Fort WorthSeptember 19, 2025#black-market#Texas#Ozempic#semaglutide#patient-harm#glp1-agonist#backfilled·nbcdfw.com·Sep 26, 2025North Texas sheriff warns of counterfeit weight loss drugs possibly linked to violent illness – NBC 5 Dallas-Fort Worth
MHRA and partners unite to reaffirm prescription weight-loss medicine advertising rules - GOV.UKSeptember 26, 2025#United-Kingdom#MHRA#glp1-agonist#advertising#regulation#backfilled·gov.uk·Sep 26, 2025MHRA and partners unite to reaffirm prescription weight-loss medicine advertising rules - GOV.UK
Chengdu Brilliant Biopharmaceutical Co., Ltd. - 711330 - 09/11/2025 | FDA#FDA#Warning-letters#APIs#CGMP-violations#glp1-agonist#semaglutide#backfilled·fda.gov·Sep 24, 2025Chengdu Brilliant Biopharmaceutical Co., Ltd. - 711330 - 09/11/2025 | FDA
motionpharmacy.com - 715595 - 09/10/2025 | FDA#FDA#unapproved-drugs#Opioids#benzodiazepines#semaglutide#injectables#Warning-letters#glp1-agonist#backfilled·fda.gov·Sep 24, 2025motionpharmacy.com - 715595 - 09/10/2025 | FDA
FDA cracks down on prescription drug ads but lacks staff | STATSeptember 17, 2025#FDA#Warning-letters#telehealth#glp1-agonist#backfilled·statnews.com·Sep 22, 2025FDA cracks down on prescription drug ads but lacks staff | STAT
FDA cracks down on online advertising of compounded GLP-1 drugs | TechTargetSeptember 18, 2025#Compounding#glp1-agonist#FDA#Warning-letters#backfilled·techtarget.com·Sep 19, 2025FDA cracks down on online advertising of compounded GLP-1 drugs | TechTarget
EA WORKS Limited Liability Company dba Trust Labs - 09/09/2025 | FDASeptember 9, 2025#Compounding#glp1-agonist#FDA#Warning-letters#retatrutide#semaglutide#tirzepatide#backfilled·fda.gov·Sep 19, 2025EA WORKS Limited Liability Company dba Trust Labs - 09/09/2025 | FDA
Eli Lilly Obesity Pill Beats Novo Nordisk Drug in Diabetes TrialSeptember 17, 2025#Eli-Lilly#Novo-Nordisk#orforglipron#semaglutide#weight-loss#glp1-agonist#backfilled·cnbc.com·Sep 17, 2025Eli Lilly Obesity Pill Beats Novo Nordisk Drug in Diabetes Trial
Novo Nordisk Inc. - 716495 - 09/09/2025 | FDA#Wegovy#Ozempic#Novo-Nordisk#FDA#Warning-letters#glp1-agonist#backfilled·fda.gov·Sep 17, 2025Novo Nordisk Inc. - 716495 - 09/09/2025 | FDA
Hims & Hers Health, Inc. dba Hers - 09/09/2025 | FDA#semaglutide#Compounding#Hims&Hers#FDA#Warning-letters#FDCA#glp1-agonist#backfilled·fda.gov·Sep 17, 2025Hims & Hers Health, Inc. dba Hers - 09/09/2025 | FDA
Eli Lilly and Company - 716485 - 09/09/2025 | FDA#Eli-Lilly#Mounjaro#Zepbound#Warning-letters#FDA#misbranded#glp1-agonist#backfilled·fda.gov·Sep 17, 2025Eli Lilly and Company - 716485 - 09/09/2025 | FDA
Lilly Weight-Loss Pill Could be FDA-Approved by Year-EndSeptember 16, 2025#Eli-Lilly#FDA#orforglipron#glp1-agonist#backfilled·ca.finance.yahoo.com·Sep 16, 2025Lilly Weight-Loss Pill Could be FDA-Approved by Year-End
Weight loss drug availability in London is 'postcode lottery' that's fuelling dangerous black market - My LondonSeptember 15, 2025#United-Kingdom#glp1-agonist#black-market#backfilled·mylondon.news·Sep 15, 2025Weight loss drug availability in London is 'postcode lottery' that's fuelling dangerous black market - My London
Weight loss jabs: Patients are using black market to obtain drugs still in clinical trials, experts warn | The BMJSeptember 11, 2025#BMJ#glp1-agonist#black-market#United-Kingdom#backfilled·bmj.com·Sep 12, 2025Weight loss jabs: Patients are using black market to obtain drugs still in clinical trials, experts warn | The BMJ